Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylphenidate for Cognitive Deficits in Chronic TBI
NCT02148783Phase 2Terminated
- Sponsor
- Uniformed Services University of the Health Sciences
- Start
- Sep 2014
- Primary completion
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of methylphenidate hydrochloride extended-release chewable tablet in traumatic brain injury (TBI), sponsored by Uniformed Services University of the Health Sciences. Started Sep 2014; status: terminated.
02
Drugs
methylphenidate hydrochloride extended-release chewable tablet
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on NCT02148783.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02148783.